CC
Claybrook Capital Portfolio holdings
AUM
$175M
1-Year Return
10.74%
This Quarter Return
+7.54%
1 Year Return
+10.74%
3 Year Return
+7.14%
5 Year Return
+9.05%
10 Year Return
–
AUM
$307M
AUM Growth
+$135M
(+78%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
42.71%
Top 10 Holdings %
Top 10 Hldgs %
32.64%
Holding
247
New
137
Increased
18
Reduced
8
Closed
83
Top Buys
| 1 |
Apple
AAPL
|
$19.1M |
| 2 |
Microsoft
MSFT
|
$12.9M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$11.7M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
$8.04M |
| 5 |
Johnson & Johnson
JNJ
|
$7.22M |
Top Sells
Sector Composition
| 1 | Technology | 20.91% |
| 2 | Healthcare | 13.77% |
| 3 | Consumer Staples | 11.35% |
| 4 | Communication Services | 9.92% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Illinois Tool Works
ITW
$77.6B
| $344K | 0.11% |
+1,539
| New | +$344K |
|
127
Enbridge
ENB
$105B
| $336K | 0.11% |
+8,381
| New | +$336K |
|
128
Paychex
PAYX
$48.7B
| $334K | 0.11% |
+3,110
| New | +$334K |
|
129
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$413M
| $329K | 0.11% |
+21,764
| New | +$329K |
|
130
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.32B
| $317K | 0.1% |
20,205
-206,818
| -91% | -$3.24M |
|
131
Progressive
PGR
$143B
| $314K | 0.1% |
+3,201
| New | +$314K |
|
132
Automatic Data Processing
ADP
$120B
| $313K | 0.1% |
+1,578
| New | +$313K |
|
133
VF Corp
VFC
$5.86B
| $310K | 0.1% |
+3,784
| New | +$310K |
|
134
Invesco Pennsylvania Value Municipal Income Trust
VPV
$180M
| $310K | 0.1% |
+23,200
| New | +$310K |
|
135
Philip Morris
PM
$251B
| $304K | 0.1% |
+3,069
| New | +$304K |
|
136
Aflac
AFL
$57.2B
| $300K | 0.1% |
+5,594
| New | +$300K |
|
137
Global X Silver Miners ETF NEW
SIL
$2.92B
| $296K | 0.1% |
+6,928
| New | +$296K |
|
138
Brown-Forman Class B
BF.B
$13.7B
| $291K | 0.09% |
+3,879
| New | +$291K |
|
139
Invesco QQQ Trust
QQQ
$368B
| $289K | 0.09% |
816
-19,150
| -96% | -$6.78M |
|
140
Colgate-Palmolive
CL
$68.8B
| $287K | 0.09% |
3,526
+226
| +7% | +$18.4K |
|
141
Stryker
SYK
$150B
| $282K | 0.09% |
+1,087
| New | +$282K |
|
142
Editas Medicine
EDIT
$248M
| $274K | 0.09% |
+4,842
| New | +$274K |
|
143
Elevance Health
ELV
$70.6B
| $272K | 0.09% |
+712
| New | +$272K |
|
144
Clorox
CLX
$15.5B
| $271K | 0.09% |
+1,507
| New | +$271K |
|
145
Schlumberger
SLB
$53.4B
| $268K | 0.09% |
+8,363
| New | +$268K |
|
146
Blackrock
BLK
$170B
| $265K | 0.09% |
+302
| New | +$265K |
|
147
Brown & Brown
BRO
$31.3B
| $265K | 0.09% |
+4,978
| New | +$265K |
|
148
Kellanova
K
$27.8B
| $257K | 0.08% |
+4,258
| New | +$257K |
|
149
GSK
GSK
$81.5B
| $255K | 0.08% |
+5,131
| New | +$255K |
|
150
Trane Technologies
TT
$92.1B
| $246K | 0.08% |
+1,336
| New | +$246K |
|